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Coccidiosis is an economically important enteric disease of poultry caused by protozoan 
parasites belonging to the genus Eimeria.  Drugs are most commonly used to control coccidiosis.  
Widespread usage of anticoccidial drugs in the field has resulted in development of drug resistant 
strains and consequently decreased drug efficacy.  An alternative control strategy using 
attenuated vaccines is desired.  A series of experiments was designed to identify, isolate and 
attenuate a strain of a common and pathogenic species of Eimeria of turkeys, E. meleagrimitis. 
Sensitivity of field isolates of turkey coccidia to the anticoccidials drugs amprolium, 
clopidol, diclazuril, and monensin was investigated.  A total of thirty-four isolates comprising 
mixed species from farms across the country were tested.  Of these, four isolates were sensitive 
to monensin, twelve sensitive to diclazuril, and seventeen sensitive to clopidol and none to 
amprolium.  One isolate, designated MN2, was sensitive to three drugs tested and was selected 
for further investigation.  The different Eimeria species present in the isolates were identified 
using polymerase chain reaction amplification of cox-1 gene and E. meleagrimitis was the most 
common species seen.  A pure clone of E. meleagrimitis was developed and the pathogenicity 
and fecundity of the isolated E. meleagrimitis strain was tested and compared to a standard 
reference E. meleagrimitis strain.  Data from the parameters tested showed that the strain had the 
same characteristics as that of the reference strain. 
An attenuated line of E. meleagrimitis was developed by repeated propagation of the 
parasite in turkeys and collection of the very first oocysts produced following infection.  After 
twenty generations of selection, a line with abbreviated life cycle of -16h was developed.  
Pathogenicity and immunogenicity of this line was tested and compared with the parent strain.  
 
 
The attenuated line was proven to be non-pathogenic but was immunogenic.  The developed line 
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Coccidiosis is a disease of high economic importance infecting young turkeys.  In most cases the 
losses are not due to mortality, but a low level infection which may result in reduced feed intake, 
lower body weights and consequently poor feed efficiency.  The disease is currently controlled 
by prophylactic use of medication mixed into the feed.  Several studies have shown that the 
parasites have developed resistance to all the drugs available in the market.  Another method of 
control is by vaccinating the birds at early age, usually at hatch, with small doses of live oocysts 
which are sprayed on to the birds or incorporated in gels.  A caveat in this method, however, is 
that there is a possibility of outbreak of clinical coccidiosis due to the virulent nature of the 
oocysts given.  It would be desirable to have an attenuated vaccine which will contain strains that 
had lost their pathogenicity but maintain their immunogenicity.  However, there are no such 
vaccines available for turkey coccidiosis. 
Eimeria meleagrimitis is one of the most common and most pathogenic species of 
Eimeria infecting turkeys.  The objective of this project was to identify a drug-sensitive strain of 
E. meleagrimitis and attenuate it by selection for precociousness.  The dissertation is divided into 
five chapters:  
Chapter I: Literature Review 
Chapter II: Sensitivity of isolates of Eimeria from turkey flocks to the anticoccidials drugs 
Amprolium, Clopidol, Diclazuril, and Monensin 
Chapter III: Molecular Detection of Field Isolates of Turkey Eimeria by Polymerase Chain 
Reaction Amplification of Cytochrome c Oxidase I Gene 
Chapter IV: A comparison of the pathogenicity and immunogenicity of two strains of Eimeria 




Chapter V: Attenuation of a drug-sensitive strain of a turkey protozoan parasite Eimeria 


























Coccidiosis is an enteric disease of high economic importance in poultry.  It is caused by 
Eimeria spp., a group of protozoan parasites belonging to the phylum Apicomplexa.  The 
organisms are present in almost every intensively reared poultry farm in the world.  The disease 
is difficult to eradicate due to at least three factors: (1) the organism’s resistant transmission 
stage of the life cycle (oocyst) that can withstand severe environmental conditions (Belli et al., 
2006); (2) the high rate of multiplication in the intestine of the host (Levine, 1985) and (3) the 
environmental conditions in intensively reared poultry houses, namely moisture, temperature and 
high humidity (Williams, 1998). 
The cost of coccidiosis to the chicken industry worldwide has been estimated as 3 billion 
dollars per annum (Williams, 1999).  Coccidiosis is also a problem in the turkey industry due to 
intensification of production (Clarkson and Gentles, 1958; Joyner, 1978).  Although the 
economics of turkey coccidiosis has not been calculated it is likely to be millions of dollars 
(Chapman, 2008) and most of this expenditure comes from the prophylactic use of anticoccidial 
drugs that involves inclusion of these agents in the feed.  Anticoccidial drug resistance has 
developed to all anticoccidial drugs introduced for use in chickens and turkeys (Chapman, 1984, 
1993, 1997; Chapman and Rathinam, 2007).  Vaccination with small doses of live oocysts has 
also been carried out to control coccidiosis.  Live vaccines available currently are either of wild-
type origin or have been attenuated by selection for precocious development.  Such attenuated 
vaccines incorporate species of Eimeria that have been undergone such selection and have 
reduced pathogenicity without losing immunogenicity (Williams, 2002a).  Although attenuated 




of this study was to identify a suitable isolate of a widespread species of Eimeria from the 
turkey, E. meleagrimitis, to characterize this parasite, and to attempt to attenuate it by precocious 
selection. 
 
HISTORY AND TAXONOMY OF EIMERIA 
 
The first recorded account of a parasite that may have been Eimeria was the discovery of 
"bodies" in the bile of rabbits by Antoni van Leeuwenhoek (1674).  Two centuries later, these 
organisms were shown to be the rabbit species Eimeria steidai (Lindemann, 1865).  In the last 
quarter of the 19th century, several researchers made independent discoveries of Eimeria by 
visualizing organisms in histological sections, observation of segmented cysts in feces 
(subsequently shown to be oocysts) and the presence of gross lesions in parasitized intestines. 
Initially, there was confusion in classifying the parasites observed in these early reports.  
Schneider (1875) named the genus Eimeria after Theodor Eimer (1843-1898) as organisms 
comprising an oocyst containing four sporocysts each with two sporozoites.  A few years later, 
Leuckart (1879) coined a generic term "Coccidium" for these organisms.  Labbe (1896) placed 
oocysts obtained from mice in the genus Coccidium and endogenous stages of the parasite 
observed in the intestines (later known as schizonts) in the genus Eimeria.  A clearer picture was 
presented in 1900 when Schaudinn described the life cycle of a parasite obtained from a 
centipede.  Based on his work, it was evident that organisms classified in two genera (Coccidium 
and Eimeria) based on their different morphology were in fact one and the same.  Thus, they 
were reclassified into one genus, and by age of discovery, and precedence Eimeria Schneider 








Credit for describing Eimeria in birds belongs to Rivolta and Silvestrini (1873) who identified a 
species they named E. avium, but Tyzzer (1929) argued that nowhere in their Italian text does the 
name "avium" appear.  Railliet and Lucet (1891) first named a species isolated from the ceca of a 
chicken as Coccidium tenellum, which they later renamed Eimeria tenella.  Smith (1895) was the 
first to report coccidiosis in the turkey.  Later, in 1916, he stated that the coccidium in turkey 
resembled neither of the two known species of Eimeria of chicken at that time, and regarded it as 
a foreign species (Smith, 1916).  Johnson (1923) reported that Eimeria of turkey resembled more 
of E. steidei seen in rabbits than Eimeria of chicken based on morphology of the oocysts.  
Johnson (1923/24) mentioned the probability of the existence of more than one species of 
Eimeria in the chicken based on oocyst morphology.  All such hypotheses preceded the 
pioneering work of Ernest Tyzzer who studied the Eimeria of gallinaceous birds.  He described 6 




Eimeria is a parasite with a monoxenous (one host) and stenoxenous (one species of host) life 
cycle.  It is predominantly a gastrointestinal parasite and is transmitted via the oro-fecal route.  A 
typical life cycle of Eimeria starts with the host passing Eimeria oocysts in feces.  These are 




Eimeria species is shown in Fig. 1. 
The first phase of the life cycle is sporogony, in which unsporulated oocysts undergo 
sporulation in the environment.  Under ideal conditions (moisture, oxygen and temperature), they 
become sporulated oocysts and are then potentially infective (Williams, 1998).  The sporulated 
oocyst contains four sporocysts, each containing two motile sporozoites.  The life cycle proceeds 
when the infective oocyst is ingested by a suitable host.  Upon reaching the gizzard the oocysts 
are subjected to mechanical grinding which releases the sporocysts (Farr and Doran, 1962).  The 
sporocysts pass into the duodenum and are exposed to protease enzymes (trypsin, chymotrypsin), 
and bile salts (Chapman, 1978).  The sporozoites are released from sporocysts (termed 
excystation) and then penetrate a host epithelial cell.  Complex molecular mechanisms are 
involved in the recognition of host cells and penetration of the host cell membrane (Chapman et 
al., 2013). 
Once inside an epithelial cell, a parasitophorous vacuole is formed around the sporozoite 
(Shi et al., 2009).  The sporozoite enlarges, loses organelles involved in cell penetration, and 
becomes a life cycle stage known as a schizont.  Nuclear division and cytokinesis then occur 
within the schizont to produce numerous motile stages known as merozoites.  The number of 
merozoites produced varies depending upon the species of Eimeria.  After the schizont matures, 
it ruptures and the merozoites are released; in the process killing the host epithelial cell.  The 
merozoites then penetrate new host cells and the process of schizogony is repeated for several 
successive generations (usually 3-4, depending upon the species). 
The final generation of merozoites penetrate epithelial cells and develop into either a 
macro or microgametocyte, a process known as gametogony.  Microgametocytes undergo yet 




penetrate a mature macrogametocyte.  This process of fertilization results in formation of a 
zygote.  A thin layer is formed around the zygote, which is followed by the formation of a 







Various biological characters and structural features of the organism are used to identify and 
differentiate species of Eimeria.  Traditional methods of identifying coccidia involve a 
combination of size and shape of oocysts and characteristic lesions seen in the host upon 
necropsy.  However, due to the overlap in characteristics of different Eimeria species in chicken 
(Joyner and Long, 1974) and turkeys (Clarkson, 1960), the possibility of an inaccurate diagnosis 
cannot be ruled out.  This is an important concern in turkey coccidiosis where there is a wide 
range in morphometry of oocysts and the lesions produced are not as distinct as seen in the 
chicken (Clarkson, 1960). 
 
Biochemical and molecular methods 
 
 Starch Gel Electrophoresis. One of the early molecular techniques for the diagnosis and 
speciation of Eimeria was starch gel electrophoresis, a biochemical method utilizing 




glucose phosphate isomerase were the most widely used enzymes to differentiate species 
(Rollinson, 1975; Shirley, 1975).  This method has been superseded by more advanced 
procedures utilizing molecular characteristics of Eimeria parasites. 
 
 DNA Hybridization. This was the first true molecular method used to identify different 
species of Eimeria in chickens.  Genomic DNA obtained from the parasite was digested using 
restriction enzymes, separated, blotted and hybridized using specific probes (Shirley, 1994).  
Apart from the need for large number of oocysts, and the time and labor involved, one limitation 
of the procedure is that mixed species show overlapping bands that cannot be separated 
(Chapman et al., 2013). 
 
 Polymerase Chain Reaction (PCR). Polymerase chain reaction is a widely used method 
in molecular biology that is used in various applications.  The principle involves amplification of 
a small copy of DNA into several orders of magnitude by making multiple copies of the DNA 
fragment.  In avian coccidiosis, the method was first utilized to identify E. tenella by amplifying 
its 5S tract of ribosomal DNA (rDNA) (Stucki et al., 1993).  This paved the way for several 
studies involving development of assays to identify Eimeria using other regions of rDNA.  The 
variability of Internal Transcribed Spacer (ITS) region of rDNA due to insertion, deletion and 
point mutations are used in identifying species-specific variations.  Both ITS-1 (Schnitzler et al., 
1998; Lew et al. 2003; Haug et al., 2007) and ITS-2 (Woods et al., 2000; Gasser et al., 2005) 
regions have been used as targets to identify all species of chicken Eimeria.  Cook et al. (2010) 
developed an assay to identify turkey Eimeria targeting their ITS-1.  Both ITS-1 and ITS-2 have 




2003).  In spite of this, intragenomic and intraspecific variation may limit its usage (Chapman, 
2013).  Cytochrome c oxidase subunit I (COI) gene, a mitochondrial gene, is now considered a 
much more reliable target for molecular species identification owing to its modest intraspecific 
variation, but sufficient DNA sequence variability strong enough for species identification 
(Ogedengbe, 2011).  
A variation in the above-mentioned PCR method is called ‘multiplex PCR’ where 
multiple primers can be amplified in a single reaction tube.  This allows identification of more 
than one species in one reaction mixture, thus minimizing reagents cost and the quantity of 
genomic DNA required.  Recently, a multiplex PCR based on ITS-1 on a single assay for four 
species of chicken Eimeria has also been developed (You, 2014).  Both the methods mentioned 
above are qualitative methods and do not quantify the amount of the specific species in a 
mixture.  Quantitative PCR (qPCR) addresses this issue by calculating the expression of the 
target gene as an absolute value based on a calibration curve or a relative value (fold change).  
Quantitative PCR assay has been developed to identify species of chicken Eimeria using the ITS-
1 (Kawahara et al., 2008) and ITS-2 regions as target (Kirkpatrick et al., 2009). 
 
CHEMOPROPHYLAXIS AND DRUG RESISTANCE 
 
Inclusion of anticoccidial drugs in the feed (prophylaxis) is the most widely used method for the 
control of coccidiosis (Chapman et al., 2013).  There is a long history of the use of drugs for this 
purpose.  The antimicrobial of choice during World War II belonged to the sulfonamide family 
and one of these, sulfanilamide, was shown to be effective against E. tenella (Levine, 1939).  




outbreaks of coccidiosis.  Another sulfonamide, sulfaquinoxaline, was shown to control 
coccidiosis when it was included continuously in the feed (Grumbles et al., 1948).  This was the 
first demonstration of the use of drugs for the prevention of the disease (prophylaxis) rather than 
the treatment of clinical coccidiosis. 
 Nicarbazin, an equimolar complex of dinitrocarbanilide and hydroxydimethyl pyrimidine, 
was introduced in 1955 (Cuckler et al., 1955) and was the first true ‘broad spectrum’ 
anticoccidial to be introduced (McDougald, 1982).  The mode of action is unknown but could be 
possibly inhibition of oxidative phosphorylation in the target organism (Wang, 1978).  Despite 
having several side effects such as growth depression and excessive mortality due to heat stress, 
it is still used today as an anticoccidial since resistance to this drug appears to develop slowly 
(McDougald, 1982). 
 Just as new drugs were being developed and discovered, resistance to previously 
introduced drugs started emerging in the field.  Cuckler and Malanga (1955) reported resistance 
to nitrofurazone, which was introduced less than a decade earlier. 
Amprolium was introduced in 1960 and was the most popular anticoccidial for about 10 
years (Chapman, 2014).  The mode of action involves inhibition of thiamine uptake by second 
generation schizonts (James, 1980).  The first report of resistance in the field to amprolium 
appeared just four years after its introduction (Chapman, 1997). 
Clopidol, a drug belonging to a group of compounds called pyridones, was introduced in 
1966. Its chemical structure is similar to another chemical group called the quinolones, and the 
mode of action is thought to be directed against the same metabolic pathway (Long, 1993).  




electron transport (Wang, 1976).  Like amprolium, resistance to clopidol developed in the field 
within a short span of three years (Chapman, 1997). 
A major breakthrough in coccidiosis control occurred in 1967 when a new class of drugs, 
the ionophorous antibiotics (ionophores) were discovered.  Unlike the synthetic chemical drugs 
used until then, this group included fermentation byproducts of a bacterium Streptomyces.  
Although first isolated in 1951 (Berger et al., 1951), their use as anticoccidials was not 
recognized until more than a decade later when one of the drugs from this group, monensin, was 
shown to have an anticoccidial effect (Schumard and Callender, 1967).  Monensin has the ability 
to enable movement of ions across cell membranes thus causing an increase in sodium ion influx 
into the sporozoite.  This increase in sodium ion stimulates osmosis and allows water to enter 
into the sporozoite and consequently due to excessive water, the sporozoite swells and bursts 
(Chapman et al., 2010).  Monensin was introduced in 1971 and since then has been the most used 
drug to control coccidiosis.  
Resistance to monensin was relatively slow to develop compared to other drugs.  Field 
isolates collected over a four-year period were tested for monensin resistance.  Of the total 256 
samples tested, only 2 samples were resistant to monensin, both being E. maxima (Jeffers, 1974a, 
b).  Reduced efficacy was seen in the field a few years later (Chapman, 1982; Mathis et al., 
1984) and resistance started building up a decade later resulting in reduced efficacy in the field 
(Chapman and Hacker, 1994). 
A similar decline in the efficacy of monensin was seen in turkey coccidiosis.  In a study 
conducted with field isolates collected from turkey farms, two groups of isolates were tested for 
monensin sensitivity.  One group was collected from birds that were fed a monensin-




exposed to monensin turned out to be resistant to the drug (Jeffers and Bentley, 1980).  In a 
battery and floor pen experiment, monensin was effective in controlling coccidiosis in turkeys 
when given a mixture of three laboratory species of Eimeria (Chapman and Saleh, 1999).  
However, in a recent battery study, of the 23 field isolates collected from commercial turkey 
farms tested for monensin sensitivity, only 6 turned out to be sensitive (Chapman and Rathinam, 
2007). 
The most recent anticoccidial drug introduced is diclazuril, an acetonitrile compound that 
was approved for use in the US in 2001.  The mode of action of diclazuril is unknown.  Kawazoe 
and Di Fabio (1994) were the first to report resistance to diclazuril in the field where 6 of the 12 




Immunity against coccidia 
 
Immunogenicity is the ability of an organism (or a particular substance, such as an antigen or 
epitope present in the organism), to develop an immune response.  Eimeria parasites are capable 
of imparting both humoral and cell mediated immunity in the host (Rose, 1987; Dalloul and 
Lillehoj, 2005).  The extent or degree of immunogenicity is different for each species of Eimeria.  
In a study that ranked species of chicken Eimeria based on their immunogenicity Eimeria 
maxima was ranked as highly immunogenic, E. acervulina as moderately immunogenic and E. 




Different strains of the same species were shown to have differing immunogenicity (Joyner, 
1969). 
Since immunity developed to one species does not provide protection against others, 
vaccines have to contain more than one species i.e. multivalent.  The number of species 
incorporated in a vaccine depends upon the target market.  Usually, vaccines intended for 
broilers contain E. tenella, E. maxima and E. acervulina and vaccines for breeders and layers 
will include E. necatrix and E. brunetti in addition to the three above-mentioned species.  This is 




Johnson (1927) found that chickens could acquire immunity when given small repeated doses of 
oocysts.  Other workers like Dickinson (1941) attempted to demonstrate the validity of vaccines 
by individual inoculation of birds.  This process, however, was not realistic for large-scale 
commercial production due to the labor involved.  Edgar was the first to bring out a commercial 
coccidiosis vaccine in 1952 against E. tenella, which was marketed by Dorn and Mitchel Labs as 
“DM Cecal Coccidiosis Vaccine” (Williams, 2002b).  A few years later, other species were 
added and after various name changes, the vaccine became Coccivac®. 
 
Live non-attenuated vaccine 
 
Edgar’s vaccine comprised live oocysts but the parasites were non-attenuated.  This kind of 




way and that are potentially pathogenic.  By giving a small dose of the vaccine, following initial 
ingestion, the bird ‘cycles’ the parasite and gets re-infected via the litter.  After 3-4 cycles, birds 
develop solid immunity.  Most coccidiosis vaccines currently sold belong in the non-attenuated 
category.  Differences among the vaccines are the number of species present, the mode of 
inoculation or other technology involved in production.  
 There are several vaccines available for the chicken.  Coccivac® (Merck) and ADVENT® 
(Huvepharma) are delivered in the hatchery via a spray where the vaccine is added to a dye and 
sprayed on chicks in boxes.  The sprayed vaccine enters the alimentary system either by the eye 
via the lachrymal ducts or by ingestion as a result of preening (Williams, 2002a).  Vaccines can 
also be given via drinking water at the farm.  ADVENT also undergoes a DNA staining assay for 
viability (Shirley et al., 2005) and claims to have an accurate number of viable oocysts in each 
dose.  Immucox® (Ceva Biomune) is delivered via bright green edible gel, which the birds feed 
on during transportation from the hatchery.  Inovocox® (Zoetis) is another broiler vaccine that 
has wild-type strains of the three Eimeria mentioned above.  It is the only in ovo coccidiosis 
vaccine (Weber et al., 2004).  Eggs are injected on day 18 of incubation and the birds shed 
oocysts following hatch.  Like other vaccines, the success of in ovo vaccination depends upon 
birds getting re-infected and ‘cycling’ the parasites in order to develop protective immunity. 
Only two vaccines are available for turkey coccidiosis and they are Coccivac®-T, a 
‘tetravalent’ vaccine containing E. adenoeides, E. meleagrimitis, E. gallopavonis and E. dispersa 
that recently has been withdrawn and Immucox®-T that is said to contain E. adenoeides and E. 
meleagrimitis. 
 





Attenuated vaccines contain strains that have lost or attenuated their virulence but maintain an 
active level of immunogenicity.  Such strains are selected either by precociousness or by serial 
passage in embryonated eggs.  
 
 Attenuation by precocious selection. The first species to be attenuated by selection for 
precociousness was E. tenella (Jeffers, 1975).  In this method, the earliest oocysts produced 
following an infection are collected, sporulated and used for a subsequent passage.  At each 
successive passage, the time between infection and appearance of first oocysts (pre-patent 
period) decreases.  This happens due to the parasites losing the last asexual generation and 
having a lower reproductive potential.  As a consequence, they decrease in virulence, but are still 
effectively immunogenic.  By selection for precociousness, the prepatent period of E. tenella has 
been reduced from 138 h to 102 h (Jeffers, 1975).  Shirley and colleagues utilized this concept in 
the 1980s and they successfully attenuated all strains of chicken Eimeria. (Table 2; summarized 
in Shirley, 1989).  These strains are marketed in Europe and other countries as Paracox® (MSD 
Animal Health) and Livacox® (Biopharm).  The only attenuated vaccine available in the US is 
Hatchpak® Cocci III (Merial), a trivalent broiler vaccine.  There is no attenuated vaccine for 
turkeys in any market. Based on published literature, there is only one report of an attenuated 
strain of turkey Eimeria, E. meleagridis (Matsler and Chapman, 2007), which was attenuated by 
selection for precociousness. 
 
 Attenuation by embryo-adaptation. Long (1965) showed that Eimeria tenella was able to 




Serial passage of E. tenella in embryonated eggs resulted in attenuated pathogenicity while 
immunogenicity was retained.  Embryo-adapted lines of E. maxima (Shirley, 1980) and E. 
necatrix (Gore et al., 1983) were also developed.  However, this method was unsuccessful in 
species other than E. tenella due to instability of the attenuation (reviewed in McDonald and 
Shirley, 2009).  The egg-adapted line of E. tenella, which was derived after more than 100 
passages, is currently used in Livacox®.  
 
Recombinant vaccine  
 
The last two decades has seen several attempts at creating recombinant DNA constructs 
developed from various Eimeria proteins.  At the time of writing this manuscript, the only 
successful recombinant vaccine is an affinity purified gametocyte antigen vaccine of Eimeria 
maxima (Wallach et al., 1989, 1995) which protects via maternal transfer of immunoglobulins to 
the young chick.  Layers are vaccinated and the antibodies produced in them are passed on to the 
offspring thus giving them passive immunity.  The E. maxima antigen has also shown to have 
partial protection against E. tenella (Smith et al., 1994).  It is commercially sold as CoxAbic® 




 DNA Vaccines. Recombinant vaccines have been developed with genes encoding 
sporozoite proteins, surface antigens and microneme proteins of sporozoites.  Kopko et al. (2000) 




SO7 and expressed in the mammalian expression vector, pcDNA3.  Birds were vaccinated 
intramuscularly and following a challenge with E. tenella, researchers were able to demonstrate 
protection, based on lesion scores and body weight data.  Another DNA vaccine developed with 
a surface antigen of E. tenella sporozoite (TA4) protected chicken following a challenge based 
on a reduction in oocyst production and decreased weight loss (Wu et al., 2004).  Other Eimeria 
sporozoite surface antigens used in DNA constructs are 3-1E (Song et al., 2001) and E. tenella 
microneme protein EtMic-1 (Qi et al., 2013), EtMic-2 (Ding et al., 2005; Sun et al., 2014). 
Various expression vectors have been used in creating DNA vaccines including bacteria 
(Salmonella; Du and Wang, 2005), Fungi (Saccharomyces; Sun et al., 2014) and plants (tobacco; 
Sathish et al., 2011).  Recombinant vaccines could be cheaper to produce en masse compared to 
the current live vaccines, as it does not include an expensive in vivo step in production.  
However, the biggest hurdle for these concepts to become reality is the variability in protection 
that they induce in vivo (Shirley et al., 2005) and the lack of reproducibility. 
 




Smith (1895) was the first to report that coccidiosis could occur in the turkey although he did not 
name the species involved.  Later, he stated that the coccidium in the turkey resembled neither of 
the two known species of Eimeria in chickens at that time, and regarded it as a foreign species 
(Smith, 1916).  The first species of Eimeria to be described from the turkey was Eimeria 




were reported (Tyzzer, 1929).  Hawkins (1950) described E. gallopavonis and in the next three 
years three more - E. adenoeides (Moore and Brown, 1951), E. innocua (Moore and Brown, 
1952) and E. subrotunda (Moore et al., 1954) were characterized.  Of the seven species, E. 
meleagrimitis, E. adenoeides and E. gallopavonis are considered most pathogenic; Eimeria 





Eimeria meleagrimitis was first described by Tyzzer (1929) along with several other species of 
chicken, turkey and pheasant Eimeria.  He regarded it as a tentative species since the oocyst 
morphology and its predilection site in the intestine was similar to that of E. mitis in the chicken.  
At the time of publication of his manuscript, he had not tested transmission of chicken Eimeria 
to turkeys and concluded that it might be E. mitis (Tyzzer, 1929).  An extensive study was 




Various prepatent periods have been reported for E. meleagrimitis.  Unfortunately in most cases 
there is lack of information on the method of data collection.  Tyzzer (1929), in the original 
description of the species, states that a development period of six days (144 hours) precedes the 
appearance of oocysts in intestinal discharges and Hawkins (1952) found that oocysts were 




meleagrimitis by collecting feces from 25 birds at 2-hour intervals.  The average prepatent period 
that he reported was 116 hr with a range of 114-118hr.  According to Reid (1972) the prepatent 
period of E. meleagrimitis is 103 hours but no reference is given for this information.  Long et al. 
(1977) also state that the prepatent period of E. meleagrimitis is 103 hours, an estimate that was 
apparently determined by measuring oocyst output “using a 24 hr collection of faeces”.  Levine 
(1985) states that the prepatent period of E. meleagrimitis is 3-6 days but no source is given for 
this information.  El-Sherry et al. (2013) state a prepatent period of 120 hours, while Vrba and 
Pakandl (2014) report 120-126 hours.  
 
Clinical signs  
 
Eimeria meleagrimitis infection does not present any classical clinical signs.  The bird exhibits 
droopiness, listlessness, palor, ruffled feathers, unthrifty appearance, huddling or looking chilled, 
mucus in the feces, diarrhea, death especially among young poults in heavy infection (Hinshaw, 
1937).  Birds also show dehydration, poor condition, and wasting. In severe cases, death is seen 
6-8 days after initial infection.  An infected bird’s feces on 6 days after ingestion of oocysts are 
foul smelling, with the production of a dark brown liquid material in the feces with small streaks 
of blood, and pieces of mucosa (Clarkson and Gentles, 1958). 
 
Pathology and lesions 
 
According to Tyzzer (1929), the parasite develops throughout the intestine of turkeys although 




and developed below the nucleus of epithelial cells with no sub epithelial forms (Tyzzer, 1929).  
The site of infection is the duodenum and upper jejunum and the lesions include an edematous, 
congested and enlarged duodenum with red brown necrotic cores. Microscopically the tips of 
intestinal villi are disrupted by gametocytes on day 5 post-infection (Clarkson, 1959).  Scanning 
electron microscopy shows extensive mucosal damage in the duodenum and jejunum but less 
destruction in the ceca. The villi were pitted and shriveled (Madden and Ruff, 1979). 
Pathogenicity is dose and age dependent and mortality can be up to 100% in 3-week old birds 




Eimeria meleagrimitis infection results in a decrease in pH in both the duodenum and the 
jejunum, but not in any other regions of the gut (Anderson et al., 1977).  A decrease in plasma 
carotenoids, an increase in aspartate amino transferase (Augustine and Thomas, 1981), and a 
decrease in plasma and liver retinol has been reported (Augustine and Ruff, 1983).  There was an 
increase in glutamic oxaloacetic transaminase (GOT) and decrease in total protein during an E. 




Long et al. (1977) characterized a strain of E. meleagrimitis isolated in Yorkshire that differed 




(16.15 x 14.75 μm compared to 20 x 17 μm of the Weybridge strain).  The Yorkshire strain was 
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Taxonomist  Group characteristics  
Phylum  Apicomplexa  Levine, 1970  Presence of apical complex  
Class  Conoidasida  Levine, 1988  Complete, hollow, truncated 
conoid  
 Order  
Eucoccidiorida
  
Leger and Duboscq, 
1910  
Undergo asexual, sexual and spore 
formation during their life cycle  
Family  Eimeriidae  Minchin, 1903  Direct life cycle  
Genus  Eimeria  Schneider, 1875  
Oocysts contain four sporocysts, 





Table 2. Comparison of reduction in prepatent period (PPP) following selection for precocious 






in PPP (h) 
Reference 
Chicken    
Eimeria acervulina 10 17 McDonald et al., 1982 
Eimeria brunetti 25 36 Shirley et al., 1986 
Eimeria maxima 12 14 McDonald et al., 1986a 
Eimeria mitis 14 26 McDonald & Ballingal, 1983 
Eimeria necatrix 15 18 Shirley and Bellatti, 1984 
Eimeria tenella 15 20 McDonald et al., 1986b 
Turkey    
Eimeria meleagridis 20 4-8 Matsler & Chapman, 2007 
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SUMMARY.  The sensitivity of field isolates of turkey coccidia from the USA to the 
anticoccidial drugs amprolium, clopidol, diclazuril, and monensin was investigated.  Clopidol 
and diclazuril were the most effective followed by monensin, and amprolium.  Thirty one 
isolates were classified as resistant to amprolium, 23 resistant to monensin, 10 resistant to 
diclazuril, and 6 resistant to clopidol.  Six isolates were partially resistant to monensin, 10 
partially resistant to clopidol, and 11 partially resistant to diclazuril.  Four isolates were sensitive 
to monensin, 12 sensitive to diclazuril, and 17 sensitive to clopidol. 
 
Key words: Eimeria, turkey, resistance, amprolium, clopidol, diclazuril, monensin 
Abbreviations: GSR = growth and survival ratio; OAA = optimum anticoccidial activity 
 
Resistance to drugs used to control coccidiosis has been extensively documented in the 
chicken, but few investigations have been carried out in the domestic turkey (2).  Anticoccidial 
agents currently approved for use in turkeys in the USA are commonly divided into two 
categories, ionophorous antibiotics that include monensin and lasalocid, and synthetic drugs 
(also known as “chemicals”) that include amprolium, clopidol, diclazuril, and others.  Resistance 
to monensin has been reported from turkey flocks, but recent studies have not been conducted 
with synthetic drugs (3, 5).  In this study, the occurrence of resistance to three such compounds 
was investigated and their efficacy compared with monensin.  Isolates were obtained from turkey 
farms throughout the USA. 
 




Animals and husbandry. Methods used, including animals and their husbandry, parasite 
collection and propagation, and evaluation of resistance, were similar to those previously 
described (3).  Female Nicholas poults were obtained from a local hatchery and raised in brooder 
cages in an isolation building. At 10 days they were transferred to a test facility and randomly 
allocated to cages (four poults/cage).  They were fed a medicated or unmedicated corn/soybean 
meal diet suitable for young turkeys.  Amprolium, clopidol, and diclazuril (Amprol® 25%, 
Coyden® 25%, and Clinacox®; Huvepharma Inc., Peachtree City, GA) were included in the 
rations at concentrations of 125, 125, and 1 ppm respectively.  Monensin (Coban® 60; Elanco 
Animal Health, Indianapolis, IN) was included in the ration at a concentration of 99.2 ppm. 
Parasites and site of development. Isolates were obtained from litter samples collected 
from turkey growing units in Arkansas, California, Iowa, Kansas, Missouri, Michigan, 
Minnesota, North Carolina, Pennsylvania, South Dakota, and Virginia, USA.  Some of the 
isolates had been used previously to determine their sensitivity to monensin (3).  No attempt was 
made to purify the isolates, which in most cases comprised more than one species.  They were 
characterized by recording whether gametocyte stages of the life cycle were present in different 
regions of the intestine.  Two poults from each unmedicated infected group were euthanatized at 
experiment termination (6 days after infection) and their intestines removed for histological 
investigation.  Samples of intestine (1 cm in length) were taken from the ascending limb of the 
duodenum, the mid jejunum, and mid cecum, fixed in 10% buffered formalin, stained with 
hematoxylin and eosin, and 5 µm paraffin sections examined for the presence of gametocytes. 
Evaluation of resistance. Six experiments were carried out in each of which 5-7 isolates 
were investigated.  Evaluation of resistance was based upon the method described by Jeffers and 




given either medicated or unmedicated feed.  Two days later they were reweighed (day 0) and 
infected with a maximum of 100,000 oocysts.  An additional two replicates were unmedicated 
and uninfected (controls).  Poults were weighed 6 days after infection and the gain in weight 
calculated.  Any mortality was recorded.  These two parameters were expressed in a growth and 
survival ratio (GSR) defined as the cage weight at trial termination plus the weight of any dead 
birds, divided by the cage weight when infected.  The percent optimum anticoccidial activity (% 
OAA) for each treatment was then calculated as follows: % OAA = [average GSR of infected 
medicated group – average GSR of infected unmedicated group] / [average GSR of uninfected 
controls – average GSR of infected unmedicated group] x 100.  An isolate was considered 
resistant if the % OAA was ≤50%, partially resistant if the % OAA was 51-74%, and sensitive if 
the % OAA was ≥75%. 
Analysis. GSR values for each experiment were combined and analyzed by one-way 
analysis of variance using the PROC ANOVA procedure of SAS software; means were 




Parasites. The site of development of each isolate is presented in Table 1.  In most cases 
gametocytes were found in the duodenum, jejunum, and ceca suggesting several species were 
present.  Identification of Eimeria in the turkey is difficult because species overlap in 
characteristics such as oocyst size and site of development (2).  Common pathogenic species that 




adenoeides; isolates are tentatively identified as these although other species, such as E. 
meleagridis and E. gallopavonis, cannot be ruled out. 
GSR. The GSR of medicated and unmedicated infected poults is presented in Table 2.  
Results for all experiments were combined and are illustrated in Fig 1.  The mean GSR for 
isolates medicated with clopidol, diclazuril, and monensin was significantly greater than the 
unmedicated infected birds.  The mean GSR for poults given clopidol and diclazuril was 
significantly greater than for birds given amprolium and monensin. 
OAA. The % OAA derived from these GSR values is presented in Table 3 and a summary of 
the resistance classification of isolates in Table 4.  Thirty one isolates were classified as resistant 
to amprolium, 23 resistant to monensin, 10 resistant to diclazuril, and 6 resistant to clopidol. Six 
isolates were partially resistant to monensin, 10 partially resistant to clopidol and 11 partially 
resistant to diclazuril.  Four isolates were sensitive to monensin, 12 sensitive to diclazuril and 17 




The sensitivity of 33 isolates of Eimeria from turkey farms in the USA to amprolium, 
clopidol, diclazuril, and monensin was investigated.  In the USA, amprolium, diclazuril, and 
monensin are approved for the control of coccidiosis in turkeys but clopidol is only approved to 
control the blood protozoan Leucocytozoon smithi.  The mean GSR for pooled isolates indicated 
that clopidol and diclazuril were the most effective followed by monensin and amprolium. The 
mean GSR for amprolium was not significantly different from infected unmedicated birds 




The extent to which these drugs had been used at the farms from which the isolates were 
obtained is not known.  A general indication of their current usage can be obtained by analysis of 
monthly data for turkey rearing complexes compiled by AgriStats Inc., Fort Wayne, New Jersey, 
USA.  During the three year period 2005 – 2007, monensin was used by 73.6% of complexes in 
at least one of the feeds given to tom turkeys.  Amprolium, clopidol, and diclazuril were used by 
2.6, 3.1, and 6.5 % of complexes respectively (Chapman, unpublished observations).  
Acquisition of resistance to Eimeria is thought to depend upon the type of drug, its mode of 
action, and the selection pressure it exerts on the coccidial population (4).  The likelihood of 
resistance is greater the more extensively a drug is used.  It is concluded that, in recent years, 
resistance has had less opportunity to develop to amprolium, clopidol, and diclazuril than to 
monensin.   
Twenty-three of the 33 isolates investigated were considered resistant to monensin, 6 
partially resistant, and 4 sensitive.  Eleven of these isolates had been utilized in a previous study 
of the sensitivity of isolates of Eimeria from turkey flocks to monensin (3).  Whereas isolates M1 
and V2 were previously considered resistant and partly resistant, respectively, in this study their 
classifications were reversed. Isolate V5, previously considered partly resistant, was judged 
sensitive to the drug.  Resistance to monensin was first reported from turkey flocks in Canada (5) 
but at that time isolates from the USA were found to be sensitive.  Monensin has been used 
extensively since its first introduction in the 1970s and therefore resistance might be anticipated. 
Thirty-one isolates were categorized as resistant to amprolium.  Resistance was documented 
in the UK in 1970 (7) but there have been no subsequent studies with this drug.  Amprolium was 
introduced in the 1960s and was used extensively in turkeys for about 20-30 years but is only 




the drinking water to treat birds diagnosed with coccidiosis, but the extent of such usage is 
unknown.  It is possible that phenotypes resistant to amprolium can survive in the environment in 
the absence of intense selection pressure.    
Twelve isolates were categorized as sensitive, 11 partially resistant, and 10 resistant to 
diclazuril.  Diclazuril was first introduced in the USA in 2001.  There have been no published 
studies of resistance, but in one report isolates obtained from farms where diclazuril had been 
used for six months produced a lower index score (a measure of pathogenicity) than isolates 
from farms where it had not been used in the year prior to collection.  This suggests that at the 
latter farms a decrease in sensitivity to diclazuril had occurred (8). 
Seventeen isolates were sensitive to clopidol, 10 partially resistant, and 6 resistant.  Clopidol 
was introduced in the 1960s, and like amprolium, resistance was documented following its 
introduction in the UK (7).  It is possible that exposure to this compound has been insufficient to 
result in the selection of many resistant strains. 
Several laboratory studies have demonstrated that it is possible to induce resistance to 
amprolium, clopidol, diclazuril, and monensin in the chicken (1).  In the turkey, however, there 
has been only one such study, in which resistance was induced to monensin (6).  Numerous 
reports have documented that in chickens resistance is widespread (e.g. 10).  Results of this study 
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Table 1. Site of development of field isolates of turkey Eimeria 
IsolateA Region of gutB  IsolateA Region of gutB 
Duo Jej Cec Duo Jej Cec 
A7 + - + M5 + + + 
A8 - + - M6 + + + 
A9 + + - M7 + + + 
C1 + + - MI1 + + + 
C2 + + - MN1 + + + 
C3 + + - MN2 + + - 
C4 + + - N1 + + + 
C5 + + + N2 + + + 
I1 - + + N3 + + + 
K1 + + + P2 + + + 
K2 + + + S1 + + - 
K3 - + + V1 + + + 
K4 + + + V2 + + + 
M1 + - + V3 + + + 
M2 + + + V4 + + + 
M3 - + - V5 + + + 
M4 + + +     
 
AIsolates preceded with the capital letters A, C, I, K, M, MI, MN, N, P, S, and V were from 
Arkansas, California, Iowa, Kansas, Missouri, Michigan, Minnesota, North Carolina, 
Pennsylvania, South Dakota, and Virginia respectively. 









None Amp Clo Dic Mon 
Experiment 1 
K3 1.685 1.621 1.802 1.758 1.703 
M1 0.745 1.126 1.657 1.658 1.366 
M3 1.284 1.357 1.735 1.625 1.381 
N1 1.235 1.352 1.694 1.480 1.480 
V4 1.056 1.311 1.611 1.529 1.365 
Experiment 2 
A7 1.390 1.432 1.754 1.619 1.779 
M4 1.278 1.336 1.740 1.484 1.317 
N2 1.508 1.470 1.643 1.643 1.513 
V3 1.187 1.291 1.732 1.203 1.270 
V5 1.196 1.277 1.540 1.628 1.637 
Experiment 3 
C2 1.062 1.003 1.362 1.058 1.103 
M5 0.961 1.079 1.055 1.220 1.030 
P2 1.004 1.107 1.339 1.271 1.082 
S1 1.042 1.078 1.344 1.139 1.134 
V2 1.127 1.072 1.287 1.414 1.143 
Experiment 4 
K1 1.039 1.200 1.479 1.524 1.418 
K4 1.236 1.121 1.506 1.693 1.414 
M2 1.075 1.081 1.101 1.736 1.477 
MI1 0.832 1.289 1.352 1.740 1.434 
MN1 1.321 1.203 1.469 1.555 1.366 




Table 2 (Contd.). 
Experiment 5 
A8 1.261 1.365 1.583 1.529 1.144 
C1 1.298 1.392 1.702 1.685 1.233 
K2 1.152 1.097 1.471 1.413 1.293 
M6 1.213 1.160 1.502 1.597 1.214 
N3 1.412 1.511 1.609 1.511 1.172 
V1 1.269 1.276 1.669 1.564 1.224 
Experiment 6 
A9 1.118 1.054 1.460 0.991 1.298 
C3 1.321 1.801 1.810 1.937 1.776 
C4 1.213 1.374 1.624 1.159 1.252 
C5 1.402 1.559 1.820 1.833 1.621 
I1 1.514 1.541 1.730 1.689 1.688 
M7 1.213 1.223 1.706 1.759 1.598 
MN2 1.577 1.769 1.666 1.761 1.749 
 
Mean 1.219c 1.301bc 1.562a 1.527ab 1.384b 
 
AIsolates preceded with the capital letters A, C, I, K, M, MI, MN, N, P, S, and V were from 
Arkansas, California, Iowa, Kansas, Missouri, Michigan, Minnesota, North Carolina, 
Pennsylvania, South Dakota, and Virginia respectively. 
BGrowth and survival ratio (GSR) = cage weight at termination / cage weight at initiation. Data 
are expressed as the average of two replicates / treatment.  Mean values followed by different 
lowercase superscripts are significantly different (P ≤ 0.01). 




Table 3. The effect of anticoccidial drugs upon the % OAA and resistance category of field 




% OAAB (resistance category in bracketsC) 
AmpD CloD DicD MonD 
Experiment 1 
K3 -66 (R)  122 (S) 78 (S) 22 (R) 
M1 37 (R) 88 (S) 84 (S) 60 (PR) 
M3 13 (R) 91 (S) 69 (PR) 20 (R) 
N1 21 (R) 84 (S) 45 (R) 43 (R) 
V4 36 (R) 75 (S) 65 (PR) 42 (R) 
Experiment 2 
A7 12 (R) 99 (S) 63 (PR) 106 (S) 
M4 12 (R) 97 (S) 43 (R) 8 (R) 
N2 16 (R) 55 (PR) 55 (PR) 2 (R) 
V3 18 (R) 96 (S) 3 (R) 14 (R) 
V5 15 (R) 61 (PR) 77 (S) 79 (S) 
Experiment 3 
C2 19 (R) 96 (S) -1 (R) 13 (R) 
M5 28 (R) 23 (R) 62 (PR) 16 (R) 
P2 28 (R) 90 (S) 72 (PR) 21 (R) 
S1 11 (R) 90 (S) 29 (R) 28 (R) 
V2 -22 (R) 64 (PR) 115 (S) 7 (R) 
Experiment 4 
K1 20 (R) 54 (PR) 60 (PR) 47 (R) 
K4 19 (R) 44 (R) 74 (PR) 29 (R) 
M2 1 (R) 3 (R) 85 (S) 52 (PR) 
MI1 45 (R) 51 (PR) 89 (S) 59 (PR) 




Table 3 (Contd.) 
Experiment 5 
A8 24 (R) 73 (PR) 61 (PR) -27 (R) 
C1 23 (R) 100 (S) 93 (S) -16 (R) 
K2 -9 (R) 58 (PR) 48 (R) 26 (R) 
M6 -11 (R) 59 (PR) 79 (S) 0 (R) 
N3 34 (R) 68 (PR) 34 (R) -83 (R) 
V1 2 (R) 93 (S) 68 (PR) -10 (R) 
Experiment 6 
A9 -9 (R) 50 (R) -19 (R) 26 (R) 
C3 101 (S) 103 (S) 130 (S) 95 (S) 
C4 28 (R) 70 (PR) -9 (R) 7 (R) 
C5 40 (R) 106 (S) 109 (S) 55 (PR) 
I1 10 (R) 76 (S) 62 (PR) 61 (PR) 
M7 2 (R) 84 (S) 93 (S) 66 (PR) 
MN2 87 (S) 40 (R) 83 (S) 78 (S) 
 
AIsolates preceded with the capital letters A, C, I, K, M, MI, MN, N, P, S, and V were from 
Arkansas, California, Iowa, Kansas, Missouri, Michigan, Minnesota, North Carolina, 
Pennsylvania, South Dakota, and Virginia respectively. 
B% OAA is the percentage of optimum anticoccidial activity. % OAA = (GSR of infected 
medicated birds – GSR of infected unmedicated birds) / (GSR of uninfected unmedicated birds – 
GSR of infected unmedicated birds) x 100. 
CAn isolate was categorized as sensitive to a drug (S) when the % OAA was ≥ 75%, partially 
resistant (PR) when the % OAA was 51%-74%, and resistant (R) when % OAA was ≤ 50%. 




Table 4.  Number of isolates of Eimeria obtained from turkey flocks classified as resistant, 
partially resistant, or sensitive to drugs. 
 
Drug Resistance classificationA 
Sensitive Partially resistant Resistant 
Amprolium 2 0 31 
Clopidol 17 10 6 
Diclazuril 12 11 10 
Monensin 4 6 23 
 
AAn isolate was categorized as sensitive to a drug (S) when the % OAA was ≥ 75%, partially 








Fig. 1. The effect of anticoccidial drugs upon the growth and survival ratio (GSR) of field 
isolates of turkey coccidia.  Data are the combined means of six separate experiments.  Values 
with different uppercase letters are significantly different (P ≤ 0.01).  Amp = amprolium, Clo = 
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MOLECULAR DETECTION OF FIELD ISOLATES OF TURKEY EIMERIA BY 
POLYMERASE CHAIN REACTION AMPLIFICATION OF CYTOCHROME 






Molecular Detection of Field Isolates of Turkey Eimeria by Polymerase Chain Reaction 
Amplification of Cytochrome c Oxidase I Gene 
 
ABSTRACT Detection of various species of Eimeria in samples collected from 30 commercial 
turkey farms using PCR was attempted.  Genomic DNA was extracted from clean oocysts from 
the field samples.  Polymerase chain amplification of species-specific cytochrome c oxidase 
subunit I (COI) gene was performed for five species of turkey Eimeria.  The species tested were 
Eimeria adenoeides, E. meleagrimitis, E. meleagridis, E. dispersa and E. gallopavonis.  Of the 
30 samples tested, all were positive for E. meleagrimitis, 9 were positive for E. adenoeides, 2 for 
E. dispersa and none for the remaining two species.  E. meleagrimitis occurred as a single 
infection in 70% of the farms while 30% of the farms had a mixed infection with E. 
meleagrimitis and E. adenoeides and 7% were triple positive with E. meleagrimitis, E. 
adenoeides and E. dispersa.  This is the first account of the field prevalence of turkey Eimeria 




Coccidiosis is an important enteric disease of turkeys and is caused by apicomplexan protozoan 
parasites of the genus Eimeria.  Infection with Eimeria is known to cause significant economic 
losses to the poultry industry (Williams, 1999).  Control of this disease relies upon the use of in-
feed anticoccidials and vaccination of birds at hatch.  Continuous usage of the drugs in the field 




Chapman (2009) showed that the field isolates of turkey Eimeria were resistant to majority of the 
anticoccidial drugs used. 
 Identification of different species of Eimeria and their prevalence is important in 
designing strategies for the prevention and control of coccidiosis.  Traditionally, epidemiological 
distribution and prevalence studies of turkey coccidiosis were based on several parasite 
characteristics (oocyst morphometry, pre-patent period, development and pathology in the host) 
and host responses (Tyzzer, 1932).  But, these methods are labor intensive, time consuming and 
less reliable due to the shared features among various species (Clarkson, 1959; Long and Joyner, 
1984).  Molecular based identification methods are gaining popularity and several assays have 
been developed for chicken (Schnitzler et al., 1998, 1999; Lew et al., 2003) and turkey Eimeria 
(Cook et al., 2010).  This study was aimed at identifying the prevalence of different Eimeria 
species in turkey field isolates using species-specific polymerase chain reaction (PCR) 
amplification of mitochondrial cytochrome c oxidase subunit I (COI) gene. 
 




Isolates were obtained from litter samples collected from turkey farms in Arkansas, California, 
Iowa, Kansas, Missouri, Michigan, Minnesota, North Carolina, Pennsylvania, South Dakota, and 
Virginia, USA.  Some of the isolates had been used previously to determine their sensitivity to 
anticoccidials drugs (Rathinam and Chapman, 2009).  Oocysts were collected from the litter 




and methods for propagation have previously been described (Chapman and Rathinam, 2007).  
All live animal protocols followed FASS (2010) guidelines for agricultural research and were 
approved by the Institutional Animal Care and Use Committee.  Upon propagation and 
sporulation, oocysts were cleaned in sodium hypochlorite and following repeated washing in 
water, were collected in Hank’s Basal Salt Solution and stored at -20°C until further use. 
 
Genomic DNA extraction 
 
Genomic DNA (gDNA) was extracted from oocysts using QiaAMP DNA Mini kit (Qiagen Inc., 
Valencia, CA) according to the manufacturer’s protocol with minor modifications as detailed 
below.  The samples were pelleted by centrifugation in a 1.5 mL micro centrifuge tube at 1500 x 
g, for 2 minutes at 4°C.  The pellet was resuspended in 500 µL ATL buffer (Qiagen) and 20 µL 
Proteinase-K (Qiagen) was added.  The suspension was then transferred to 1.5 mL screw cap 
tubes with 200 mg of sterile glass beads (̴ 0.5 mm diameter).  The oocysts were disrupted using a 
mini-BeadBeater (Biospec Products, Bartlesville, OK) twice for 2 minutes with 1 minute 
incubation on ice in between.  The supernatant was collected into a new collection tube and the 
gDNA was extracted according to the kit instructions. The eluted DNA was stored at -20°C for 
further use. 
 
Polymerase chain reaction 
 
Identification of Eimeria sp. in each sample was performed by PCR amplification of the species 




(Applied Biosystems, Foster City, CA).  The primers used were kindly provided by Dr. John R. 
Barta (University of Guelph, ON, Canada) and their sequences are shown in Table 1.  The 
reaction mixture for each sample comprised 5μL of gDNA, 12.5 μL of PCR master mix 
(Promega Corporation, Madison, WI), 400 nM forward primer, 400 nM reverse primer, and 
nuclease-free water to make up a final volume of 25 μL.  The cycling conditions used were one 
cycle at 95°C for 10 min, and 39 cycles at 94°C for 30 s, 50-62°C for 45 s, 72°C for 1 min, and a 
final extension at 72°C for 10 min.  Negative controls were included to check for nonspecific 
amplification of primers.  Genomic DNA isolated from single oocyst lines of turkey Eimeria 
species characterized in our laboratory (E. adenoeides, E. meleagrimitis, E. meleagridis and E. 
dispersa) were used as positive control.  No positive control was included for E. gallopavonis 
due to unavailability of a pure line, but the primer had been tested for amplification of E. 




The amplification products were analyzed on 1% agarose (Promega) gel electrophoresed at 100 
V in TBE buffer (Life Technologies, Grand Island, NY).  A GeneMate Quanti-Marker 100 bp 
(BioExpress, Kaysville, UT) DNA ladder was used as the size standard.  Ethidium bromide was 
incorporated into the gels as the nucleic acid staining agent and the gels were analyzed under UV 







Of the five turkey Eimeria species investigated, only three species were seen in the samples (E. 
adenoeides, E. meleagrimitis, and E. dispersa).  E. meleagridis or E. gallopavonis were not 
identified (Table 2).  The most prevalent species was E. meleagrimitis (30/30; 100%), followed 
by E. adenoeides (9/30; 30%) and E. dispersa (2/30; 7%). 
 Presence of only one species (E. meleagrimitis) was seen in 21 isolates (70%), whereas 
mixed species with two or more species was seen in 9 isolates (30%).  Frequencies of various 
species in a mixed isolate are given in Fig 2.  The most prevalent mixture was E. adenoeides and 
E. meleagrimitis with 7 isolates (24%) testing positive for this mixture.  Two isolates (7%) were 




Knowledge of the distribution and prevalence of Eimeria species in the turkey is lacking 
and such information would play an important role in identifying appropriate control tools and 
strategies.  Several reports have been published showing the prevalence of chicken Eimeria 
species in the field (Lee et al., 2010; Ogedengbe et al., 2011), but no such reports exist for the 
turkey.  In this study, the prevalence of different species of Eimeria in turkey field isolates was 
investigated.  We used a species-specific COI based PCR assay to identify five species of turkey 
Eimeria (E. adenoeides, E. meleagrimitis, E. meleagridis, E. dispersa, and E. gallopavonis).  
 Over the years, several species-specific PCR diagnostic assays have been developed to 
identify chicken Eimeria.  These assays target different loci like internal transcribed spacer-1 
(ITS) (Schnitzler et al., 1998, 1999; Lew et al., 2003; Su et al., 2003; Haug et al., 2007, 2008), 




1993; Tsuji et al., 1997).  Cook et al. (2010) developed ITS-1 based PCR for the diagnosis of 
turkey Eimeria.  Though ITS based assays are being used widely for species identification, the 
intragenomic and intraspecific variations in these sequences may limit its usage (Chapman et al., 
2013).  COI gene is now considered a much more reliable target for molecular species 
identification owing to its modest intraspecific variation, but sufficient DNA sequence variability 
strong enough for species identification.  The presence of this gene in multiple copies in Eimeria 
genome also makes it a good PCR target (Ogedengbe et al., 2011).  Considering the various 
advantages of COI over ITS-1 for species identification, we have used a COI based PCR assay to 
determine prevalence in our experiment.  
 E. meleagrimitis was identified as the most prevalent species in the field and was 
detected in all of the single infections and co-infections observed in the study.  The second most 
prevalent species was E. adenoeides (30%) and was found in 100% of the mixed infections.  
Only 7% of the total samples tested were positive for E. dispersa.  E. meleagrimitis and E. 
adenoeides are considered as the two most common pathogenic species in turkeys.  This supports 
an earlier finding that E. meleagrimitis was the most prevalent species (Jeffers and Bentley, 
1980).  Of the 38 isolates they tested, a majority comprised two species E. meleagrimitis and E. 
adenoeides, 10 contained predominantly E. meleagrimitis and one E. adenoeides (Jeffers and 
Bentley, 1980).  A survey was conducted on the prevalence of turkey Eimeria in 13 turkey 
producing states in the 1960s and showed that E. meleagrimitis was identified in 22 farms while 
E. adenoeides was seen in 34 farms.  However, when the survey was repeated in 1982-83, of the 
39 isolates tested, the number of samples containing E. meleagrimitis was 33 while E. 





 This is the first report of the field prevalence of turkey Eimeria species using molecular 
methods.  This report identifies E. meleagrimitis as the most prevalent species.  Currently there 
are only two vaccines available for turkey coccidiosis, both of which are live, wild-type 
vaccines.  Possibility of vaccine failure and risk of an outbreak of clinical coccidiosis is quite 
high in wild-type vaccines (Williams, 2002).  It would be desirable to have an attenuated vaccine 
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Table 1. DNA sequence, annealing temperatures of COI primers for turkey Eimeria Sp. 
 



























































Table 2. Results from the COI PCR of turkey field isolates 
Isolatea 
Species testedb* Single 
infection 
Mixed 
infection ADE MEL DIS 
A7 - + - + - 
A9 - + - + - 
C2 + + - - + 
C4 - + - + - 
C5 - + - + - 
C6 + + - - + 
C7 - + - + - 
C8 + + + - + 
IA1 - + - + - 
IA2 - + - + - 
K1 - + - + - 
K3 + + - - + 
K4 + + - - + 
M1 - + - + - 
M2 + + - - + 
M4 - + - + - 
M6 - + - + - 
M8 - + - + - 
M9 + + - - + 
M10 - + - + - 
M11 - + - + - 
MI1 - + - + - 
MN1 - + - + - 
MN2 - + - + - 
N3 + + + - + 
P1 - + - + - 
P2 - + - + - 
S1 - + - + - 
V1 - + - + - 
V2 + + - - + 
Total 9 30 2 21 9 
 
aIsolates preceded with the capital letters A, C, I, K, M, MI, MN, N, P, S, and V were from 
Arkansas, California, Iowa, Kansas, Missouri, Michigan, Minnesota, North Carolina, 




bSpecies of Eimeria tested were ADE (E. adenoeides), MEL (E. meleagrimitis), DIS (E. 
dispersa).  
*None of the samples tested were positive for MED (E. meleagridis) and GAL (E. gallopavonis) 







Fig 1. Agar gel electrophoresis of PCR product obtained by amplification of gDNA from N3 
isolate using species specific COI primers against turkey Eimeria.  ad-Eimeria adenoeides; mt-E. 
meleagrimitis; md-E. meleagridis; ds-E. dispersa; gl-E. gallopavonis. First lane on the left 









Fig 2.Frequency distribution of Eimeria meleagrimitis (MEL), E. adenoeides (ADE) and E. 
dispersa (DIS) co-infection in litter samples collected from 30 turkey farms in the USA.  Eimeria 
































A COMPARISON OF THE PATHOGENICITY OF TWO STRAINS OF EIMERIA 





Comparison of the Pathogenicity of a Newly Isolated Field Strain of Turkey Coccidium 
Eimeria meleagrimitis and a Reference Strain 
 
ABSTRACT. The pathogenicity of a strain of Eimeria meleagrimitis (Minnesota strain) was 
evaluated in the current study by comparing it to a reference strain (Weybridge strain).  Two-
week old poults were infected with 1 x 104, 5 x 104 or 1 x 105 sporulated oocysts of each strain.  
Body weight gain, feed consumption and feed conversion were estimated from days 0 to 6 post- 
infection.  Lesions in the intestines and fecal droppings were scored on day 6 following infection 
based upon a new system that was established.  The Minnesota strain showed significantly lower 
pathogenicity  at the lowest dose tested (1 x 104 oocysts)  At higher levels of infection, both 
strains exhibited significantly high pathogenicity.  The Weybridge strain was more pathogenic 




Protozoan parasites of the genus Eimeria cause the disease coccidiosis in poultry; an infection 
that can result in a variety of adverse pathological effects in the host (McDougald, 2003).  One of 
the most important coccidia of the turkey is Eimeria meleagrimitis that infects the duodenum and 
jejunum (Tyzzer, 1929; Clarkson, 1959).  An infection with E. meleagrimitis can cause an 
edematous and congested duodenum, erosion of large areas of epithelium, a brownish mucoid 
exudate, scattered hemorrhages and watery diarrhea (Joyner, 1973). 
PCR identification of various turkey field isolates conducted in our laboratory showed E. 




pure line of E. meleagrimitis was established from a drug sensitive isolate by single oocyst 
isolation (Shirley and Harvey, 1996).  The objective of this experiment was to determine the 
pathogenicity of the recently isolated E. meleagrimitis strain and compare it with a known 
reference (Weybridge) strain. 
 
MATERIALS AND METHODS 
 
Birds and husbandry 
 
Female Nicholas turkey poults were obtained from a local hatchery and raised in a brooder in an 
isolation building at a stocking density of 257 cm2 / poult.  They were fed an unmedicated corn 
/soybean meal diet suitable for young turkeys and provided with water ad libitum.  At 13 days of 
age poults were weighed and transferred to a test facility and randomly allocated to cages in 
battery units that had been thoroughly cleaned and fumigated with concentrated ammonia 




A pure isolate of E. meleagrimitis was kindly provided by Dr. R. N. Marshall of the Veterinary 
Laboratories Agency (Weybridge), Surrey, UK.  This strain had originally been isolated from 
turkey poults in 1965 in the UK and is referred to as the Weybridge strain (Hein, 1969). 
A field isolate of E. meleagrimitis was isolated from a litter sample received from a turkey 




method described by Shirley and Harvey (1996) and was subsequently propagated turkeys reared 
in isolation.  Various criteria were used to establish the identity of the pure strain including the 
presence of macrogametocytes in histological sections of the jejunum, and the size of the oocysts 
(length x width approximately 20 x 17 µm).  For each experiment, cultures were less than a 
month old when used.  Laboratory procedures for all propagations followed guidelines for 




The experiment comprised seven treatments, each with four replicate cages containing six birds / 
cage.  Treatments 1-3 comprised poults that were orally inoculated one day after placement in 
cages (14 days of age) with 1 x 104, 5 x 104, or 1 x 105 oocysts of the Weybridge strain.  
Treatments 4-6 comprised poults given the same doses of the Minnesota strain.  Treatment 7 
comprised poults that were sham inoculated with water (uninfected controls).  
 
Weight gain, feed intake, feed conversion, and mortality  
 
Bodyweight gain of poults was determined from day 0 to 6 following infection.  The amount of 
feed consumed from day 0 to 6 was determined and feed conversion calculated.  The intestines 
of any birds that died during the course of study were examined to determine if coccidiosis was 







Two birds from each cage (8 poults / treatment) were killed on day 6, their intestines removed, 
and the jejunum examined for characteristics indicative of coccidiosis.  It proved difficult to 
provide a subjective score for the severity of the host response to infection.  A variety of 
pathological effects were observed which were inconsistently present in poults from the same 
treatment.  These included congestion of blood vessels, edema, pale coloration, and a thin 
intestinal wall and occasionally an enlarged intestine, the presence of necrotic cores, and 
petechiae in the intestinal wall.  A lesion scoring system was developed by utilizing the first four 
criteria (congestion, fluid, pale coloration, and a thin intestinal wall).  A point was allocated for 
each of these criteria so that for each poult examined a maximum of four points was possible.  
The mean value for the eight poults in each group was then calculated. Birds that died due to 




Feces were scored subjectively on a scale of 0-3 based upon the form of the droppings, their 
color, the extent of diarrhea, and the presence of any mucus or blood.  A score of zero was given 
if individual droppings were normal in appearance (short and rounded in shape, green in color 
often with a covering of white urate crystals), and dry with no evidence of diarrhea, blood, or 
mucus.  A score of 1 was given if the droppings were discrete but loose in structure, often 
sausage-like in shape, green to brown in color, with scattered patches of diarrhea in the tray.  A 
score of 2 was given if half of the droppings had no shape or form, they were brown to orange in 




were minimally formed with no discrete structure, were orange-brown in color with red regions, 




Cages were assigned by a completely randomized design with four replicates per treatment. All 
data were analyzed by one-way ANOVA using SAS Enterprise Guide 6.1 (SAS Institute, Cary, 





Weight gain and Mortality 
 
Significant reductions in weight gain compared with uninfected poults were evident from days 0-
6 following infection with both strains of E. meleagrimitis (Table 1).  No significant differences 
in weight gain were found in poults whether they were given 5 x 104 or 105 oocysts of either 
strain.  However, poults given 104 oocysts of the Minnesota strain gained more weight from days 
0-6 than poults given 104 oocysts of the Weybridge strain.  One bird died on day 6 after infection 
with 105 oocysts of the Weybridge strain but no deaths occurred in other treatments. 
 





Feed consumption was significantly reduced compared with uninfected poults from days 0-6 
following infection with both strains of E. meleagrimitis.  No significant differences in feed 
intake from days 0-6 were found in poults given 5 x 104 or 105 oocysts of either strain.  Poults 
given 104 oocysts of the Minnesota strain consumed more feed than poults given 105 oocysts.  
With the exception of poults given 104 oocysts of the Minnesota strain, infected poults had 




Mean lesion scores are presented in Table 1.  No lesions were found in uninfected birds and 
poults given 5 x 104 and 105 oocysts of the Minnesota strain had a significantly greater lesion 
score than poults given 104 oocysts.  A significant increase in lesion score was seen in poults 
given higher doses of the Weybridge strain.  Poults given 105 oocysts of the Weybridge strain 




Poults infected with the Minnesota strain showed an increase in dropping score as the number of 
oocysts given increased (Table 1).  On day 6 after infection the severity of score was 
proportional to the dose of oocysts administered for the Minnesota strain of E. meleagrimitis but 
not for the Weybridge strain of that species.  Poults given the Weybridge strain had higher 







E. meleagrimitis is a pathogenic species that infects the turkey Eimeria (Hawkins, 1950; 
Clarkson, 1959).  The pathogenicity of the reference strain (Weybridge strain) used in this study 
has been established (Hein 1969; Long et al., 1977).  A lesion and fecal dropping score system 
was developed in the current study in an attempt to standardize subjective study criteria.  Based 
on body weight gain, the Minnesota strain was less pathogenic at the lower dose (104) compared 
to the Weybridge strain.  Nonetheless, the Minnesota strain suppressed body weight significantly 
even at the lowest dose tested confirming that it was pathogenic.  While no mortality was seen in 
the birds infected with the Minnesota strain, there was slight mortality (4 %) in poults infected 
with the Weybridge with a dose of 105 oocysts.  Feed consumption and feed conversion data 
support the findings seen with body weight gain.  
Existence of strain variation among various species of Eimeria has been reported earlier 
and differences in such strains have been based on physical characteristics, immunogenicity and 
pathogenicity.  Joyner reported difference in immunogenicity of two strains of E. acervulina 
(Joyner, 1969) and E. tenella (Joyner and Norton, 1969).  In the latter study, comparison of the 
Weybridge and Houghton strains of E. tenella showed that the Weybridge strain was more 
pathogenic (as seen by cecal lesions) than the Houghton strain (Joyner and Norton, 1969).  In 
turkeys, Long et al. (1977) reported a strain of E. meleagrimitis (Yorkshire strain) which had 
smaller oocysts than previously described for that species.  The strain was confirmed to be E. 
meleagrimitis by cross protection test and enzyme analysis. 
Pathogenicity of the Minnesota strain is compared to the Yorkshire strain (Long et al., 




Long et al. (1977), the Yorkshire strain appears to be less pathogenic at 5 x 104 compared to both 
Weybridge and Minnesota strains.  The higher doses did not have a dose dependent body weight 
decrease in birds infected with any strain.  
The criteria used for evaluation of pathogenicity include body weight gain, feed 
consumption, feed conversion, lesion score and fecal dropping score.  A system was developed 
for lesion and fecal scoring of E. meleagrimitis with an objective of describing each score.  A 
lesion scoring system has been used extensively in chickens to evaluate the efficacy of 
anticoccidial drugs (Johnson and Reid, 1970).  Thus, for the cecal parasite Eimeria tenella, 
lesions in the ceca were graded from 0 to 4 based upon a literature review of pathological signs 
of infection.  Lesion scores have been used to evaluate Eimeria infection in the turkey but no 
description of the actual pathological signs associated with scores of different values has been 
provided (e.g. Mathis, 1993; McDougald, 1976, 1986; Mitrovic, 1968).  Thus, a score of 0-4 was 
assigned based upon visual evaluation of intestinal damage (Mathis, 1993).  In another study, 
intestinal lesions were scored on a scale of 0-3, where scores of 1, 2, and 3 indicated any 
detectable lesions, moderately severe lesions, and most severe lesions, respectively, (McDougald 
1986).  Jeffers and Bentley (1980) concluded that the characteristics of the lesions produced by 
turkey coccidia do not readily permit the use of a definitive lesion scoring system such as that 
used in chickens.  
Fecal dropping scores have been used to evaluate Eimeria infections in the turkey but the 
actual methods employed have not been described in detail.  For example, McDougald (1986) 
utilized a scoring system from 0 to 3 that was a subjective assessment of the extent of diarrhea 
and presence of mucus and blood in the droppings.  In this study, we use a similar system and 




their color, the extent of diarrhea, and the presence of any mucus or blood.  We show that on day 
6 after infection the severity of score is proportional to the dose of oocysts administered for the 
Minnesota strain of E. meleagrimitis but not for the Weybridge strain of that species (Table 1). 
The Minnesota strain of E. meleagrimitis showed significantly less pathogenic effects at the 
lowest dose tested (1 x 104 oocysts) based on all the parameters tested and at higher levels of 
infection, both strains exhibited significantly high pathogenicity.  The Weybridge strain was 
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Table 1. Bodyweight gain, feed intake, feed conversion, mortality, lesion score, and dropping 



















Uninfected 0 237±6 a 342a 1.45b 0 0c 0 d 
Minnesota 
strain 
1 x 104 141±5 b 277b 1.96b 0 0.5c 1.0c 
5 x 104 96±9 c 254bcd 2.84a 0 2.375b 2.0b 
1 x 105 92±4 c 248cd 2.70a 0 2.75b 3.0a 
Weybridge 
strain 
1 x 104 102±9 c 273bc 2.72a 0 0.75c 2.75ab 
5 x 104 85±4c 244d 2.89a 0 2.75b 2.75ab 
1 x 105 79±5 c 253bcd 3.21a 4 3.75a 2.0b 
 
Values in columns with no common superscript differ significantly (P ≤ 0.05). Each observation 
is the mean for four cages each containing six poults. 
1Number of oocysts administered / poult. 
2Mean bodyweight gain / poult ± SEM from day 0-6 after infection. 
3Mean feed consumption / poult from day 0-6 after infection. 
4Feed conversion was calculated by dividing feed intake by bodyweight gain. 
5Lesion scores were based upon four criteria (congestion, edema, pale coloration, and a thin 
intestinal wall) for which a point was allocated (maximum of four points / poult). The mean 
value for eight poults (two poults from four cages of each treatment) was then calculated. 





Table 2. Body weight gain (in % compared to uninfected controls) from days 0-6 (present study) 
or 0-7 (Long et al., 1977) following an infection with various strains of E. meleagrimitis 
 
Dose 
Body weight gain (%) 
Yorkshire strain1 Weybridge strain2 Minnesota strain2 
0 100 100 100 
1 x104 Not done 59 43 
5 x 104 63 34 40 
1 x105 35 33 39 
 
1 Data from Long et al., 1977 





















ATTENUATION OF A DRUG-SENSITIVE STRAIN OF A TURKEY PROTOZOAN 




Attenuation of a Drug-sensitive Strain of a Turkey Protozoan Parasite Eimeria 
meleagrimitis by Precocious Selection 
 
ABSTRACT An attenuated line of Eimeria meleagrimitis was established by repeated 
propagation of the parasite in 9-day old turkey poults and subsequent selection for precocious 
development.  Following 20 passages, the prepatent period decreased from 120 hours to 104 
hours.  A series of experiments were conducted to evaluate the pathogenicity, immunogenicity 
and fecundity of the newly selected attenuated line.  Fourteen-day old poults were infected with 
5x104 oocysts of either the parent strain or the attenuated line to ascertain pathogenecity.  Judged 
by body weight gain, feed consumption and feed efficiency following infection, the attenuated 
line proved to be non-pathogenic.  The immunogenicity of the attenuated line was tested by 
infecting poults with incremental doses of 102, 103 and 104 oocysts at 0, 7, and 14 days of age 
respectively with either the parent strain or the attenuated line.  Twelve days following the last 
inoculation, all birds were challenged with 5 x 102 oocysts of the parent strain, and oocyst 
production from 96-168 hours following challenge was determined.  No oocysts were seen in 
both the groups following challenge, indicating that the attenuated line is as immunogenic as the 
parent strain.  The fecundity was assessed by infecting two-week old birds with 5x102 oocysts of 
either parent or attenuated strain, and oocysts produced in the feces were counted at 12-hour 
intervals from 96 to 240 hours post-infection.  Oocyst production showed that the attenuated line 







Coccidiosis is an important disease of domestic livestock caused by protozoan parasites of the 
genus Eimeria.  The disease is particularly important in the poultry industry where large-scale 
confinement at high stocking densities has provided ideal conditions for transmission.  Seven 
species of Eimeria have been described from the turkey and several of these are considered 
pathogenic (Chapman, 2008).  Infection can result in reduced feed intake, lowered weight gain, 
impaired absorption of nutrients and death. 
At present, control of coccidiosis in the turkeys is achieved by administering 
anticoccidial drugs in the feed and millions of dollars are spent annually for this purpose.  
Several compounds are approved but their efficacy has been compromised by the development 
of drug resistance (Chapman and Rathinam, 2007; Rathinam and Chapman, 2009).  An 
alternative to chemotherapy is immunization of turkeys against coccidiosis.  This is feasible 
since infection with the species of Eimeria that parasitize the turkey can induce a protective 
immune response.  Vaccines are available for immunizing turkeys against coccidiosis but the 
strains used are virulent and can, by recycling in susceptible birds, can cause the disease the 
vaccine is intended to prevent.  Eimeria meleagrimitis is one of the most pathogenic species of 
Eimeria that infect turkeys (Clarkson, 1959; Ruff et al., 1980; El-Sherry et al., 2013; Vrba and 
Pakandl, 2014).  
The objective of this study was to develop a line of Eimeria meleagrimitis that has lost its 
pathogenicity but is capable of protecting the turkey against challenge with virulent strains.  This 
was done by selecting for ‘precociousness’, which involves serial passage following collection of 
the earliest shed oocysts and passaging in fresh birds, each time attempting to collect at an earlier 
time than before.  By doing so, the time between the infection and appearance of oocysts in the 




pathogenicity.  The term was first coined by Jeffers (1975) when he successfully demonstrated 
the technique with Eimeria tenella.  
 
MATERIALS AND METHODS 
 
Experiment 1: Isolation of precocious E. meleagrimitis 
 
Birds and husbandry. Female turkey poults (Nicholas breed) were obtained from a local 
hatchery, transferred to an  isolation building, and reared in brooder cages at a stocking density 
of 257 cm2/poult until they were 9 days of age.  Husbandry and management followed guidelines 
for the care and use of agricultural animals in agricultural research (FASS, 2010) and all 
experiments were approved by the University of Arkansas Animal Care and Use Committee.  At 
9 days of age poults were transferred to a test facility and randomly allocated to clean grower 
cages (five poults/cage).  Poults were fed a corn/soybean meal diet formulated according to 
starter feed requirements for turkey poults.  
 
Parasites. Parasites were isolated from field samples received from commercial turkey 
farms as described previously (Chapman and Rathinam, 2007).  Parasites collected from such 
field samples comprised a mixture of species and no attempts were made to purify them.  They 
were subjected to a drug sensitivity test (Rathinam and Chapman, 2009) using anticoccidial 
drugs commonly used in turkey farms.  One strain that was sensitive to the tested drugs and 
showed parasite development in the small intestine (MN2; Rathinam and Chapman, 2009) was 




established following a single oocyst isolation using established methods (Shirley and Harvey, 
1996).  This was designated the “parent” strain and used in the current study. 
 
Selection procedure. Selection of precocious line followed procedures similar to those 
that were successful in the chicken (reviewed in McDonald and Shirley, 2009) and turkey 
(Matsler and Chapman, 2007).  This involved collecting the very first oocysts produced 
following infection with the parent strain and serial propagation of successive generations in a 
new flock of turkeys.  Groups of 5, 9-day-old poults were infected orally with 5 x 103 sporulated 
oocysts of the parent strain of E. meleagrimitis.  Based on available literature, the prepatent 
period (PPP) of E. meleagrimitis could be as early as 103 hours (Reid, 1972).  Hence, feces 
produced by infected birds from 0–100 hours post-inoculation (HPI) were discarded and 
subsequently collected from each group at 4-hr intervals. 
Oocysts recovered from each 4-hr fecal collection were counted (minimum number 
detectable was approximately 0.3x103 oocysts/bird) and sporulated by methods described by 
Long et al. (1976).  Viable oocysts collected from the earliest time point were then given to a 
second group of poults.  This process was repeated for 20 successive generations in further 
groups of birds (Table 1).  For each generation, an attempt was made to obtain oocysts at an 
earlier time interval than in the previous passage.  At each passage, collections at later time 
intervals were also made as a backup in the event of failure of oocysts collected from an earlier 
time point.  The intended dose of 5x103 oocysts/bird was given when possible except in passages 
where the number of oocysts produced were less than required to dose the next batch of birds 
with 5 x 103 oocysts.  In such cases, the available oocysts were used for dosing the subsequent 





Experiment 2: Evaluation of precocious E. meleagrimitis 
 
Pathogenicity. Four groups of 5 poults were inoculated with 5x104 oocysts of either the 
precocious line or parent strain at 14 days of age.  They were weighed on days 0, and 6 after 
infection, and weight gain was determined.  A further four groups of five birds were uninfected 
and served as controls.  The pathogenic dose was selected based on the dose titration study.  A 
dose of 5x104 oocysts of the parent strain caused a significant reduction in weight gain 6 days 
after infection without significant mortality (Chapter 4, page 79).  Feed consumption for the 
study period (Day 0-6) was measured and feed conversion estimated. On Day 4 post-infection, 
fecal trays were cleaned out. A dropping score (Chapter 4, page 79) was given on day 6. 
 
Immunogenicity. Thirty poults were placed in six cages (five birds/cage) and inoculated 
on a weekly basis (at 0, 7, and 14 days of age) with 102, 103, and 104 oocysts of the precocious 
line or the parent strain of E. meleagrimitis respectively.  Another set of 15 poults were raised in 
a separate facility but not infected (uninfected controls).  At 25 days, all birds were challenged 
with 500 oocysts of the parent strain of E. meleagrimitis, and the number of oocysts produced in 
the feces from day 4–8 was recorded. 
 
Fecundity. On Day 14 of age, forty poults were placed in eight cages (five birds/cage) 
and inoculated with 5x102 oocysts, respectively, of the precocious line or the parent strain of E. 




at 96 HPI and continued until 240 HPI.  Oocysts were counted by standard techniques and the 




Cages were assigned by a completely randomized design with four replicates (three in 
immunogenicity study) per treatment.  All data were analyzed by one-way ANOVA using SAS 
Enterprise Guide 4.3 (SAS Institute, Cary, NC).  Mean separation was done by Student-




Experiment 1: Isolation of precocious E. meleagrimitis 
 
The prepatent period of the ‘parent’ strain was 120 hours.  The successive passages and 
reduction in PPP are shown in Table 1. After 20 passages, the PPP was 104 hours.  The earliest 
shed oocysts in some generations did not produce progeny (Table 1; Passages 4, 9, 10, 13, 16). 
Progeny of oocysts collected from the next time point (4 hours later) of that passage were used in 
subsequent passages. 
 





Pathogenicity. Results of the pathogenicity study are given in Table 2.  The birds that 
were infected with the precocious line had significantly higher body weight gain compared to 
birds that received the parent strain.  Poults that received the precocious line consumed more 
feed than those that received the parent strain, but significantly less than controls.  Feed 
conversion of birds infected with precocious line was no different from controls.  Birds that 
received the parent strain had a significantly poor feed conversion.  Birds infected with the 
parent strain had a high dropping score while the other groups in the study received no score.  
 
Immunogenicity. Poults that were not immunized and challenged with 500 oocysts of the 
parent strain produced oocysts (31.2 x 106 oocysts per bird).  Birds that were immunized with the 
parent strain and the precocious line and challenged with the parent strain did not produce any 
oocysts (Table 3). 
 
Reproduction. The earliest time point g that oocysts were observed in the feces was 108 
hours for the precocious group and 120 hours for the parent line (Fig. 1).  Oocyst production of 
the parent strain peaked at 156 hours with 158 x104 oocysts produced per bird.  The spike in 
birds infected with the precocious line, however, was earlier at 120 hours with 68 x105 oocysts 
produced per bird.  By 240 hours following infection, the oocyst output in precocious line had 








its pathogenicity, immunogenicity and fecundity was evaluated by comparing it with the parent 
strain.  The PPP of E. meleagrimitis has been reported to be as short as 103 h (Reid, 1972; Long 
et al., 1977) to as long as 144 HPI (Tyzzer, 1929; Hawkins, 1952).  Other reports have 
mentioned time points in between including 116 (Clarkson, 1959), 120 (El-Sherry et al., 2013), 
120-124 (Vrba and Pakandl, 2014) hours after infection.  Levine (1985) states a wide range of 3-
6 days of PPP.  In our study, based on a four-hour collection procedure, the PPP of the parent 
strain was 120 hours. 
Selection of a strain for precociousness was first described by Jeffers (1975) who 
attenuated the pathogenic chicken species, E. tenella.  By collecting the very first oocysts that 
were produced and subsequently propagating those oocysts, there was a reduction in PPP of 12-
18 hours (Jeffers, 1975).  Other species of chicken Eimeria have also been attenuated by this 
method following several generations of propagation.  The PPP of E. brunetti was reduced by 36 
h following intense selection for 25 generations (Shirley et al., 1986) while that of E. maxima 
was reduced by 14 h after 12 generations (McDonald et al., 1986a).  After 15 generations of 
selection, the PPP of E. necatrix (Shirley and Bellatti, 1984) and E. tenella (McDonald et al., 
1986b) reduced by 18 and 20 h respectively.  There was a reduction of 17 h following 10 
generations of selection with E. acervulina (McDonald et al., 1982) and 26 h after 14 generations 
with E. mitis (McDonald and Ballingal, 1983).  In turkey Eimeria, the only available record of 
attenuation is that of E. meleagridis where there was an 8 h decrease in PPP after 20 generations 
of selection (Matsler and Chapman, 2007).  In the current study, PPP of E. meleagrimitis 
decreased from 120 h to 104 h after selection for 20 generations (Table 1). 
Attenuation of a strain occurs when the parasite loses an asexual generation during its life 




during schizogony (Jeffers, 1975).  In all the chicken studies mentioned above, the parasites that 
were attenuated by precocious selection had lost at least their last generation of schizogony 
(Long, 1993).  In the current study modification in life cycle of the attenuated line was not 
investigated.  The production of oocysts following a low dose of infection showed that the 
reproducibility of the attenuated line was low and that it peaked earlier compared to the parent 
strain (Fig. 1). 
Birds infected with E. meleagrimitis has been shown to develop solid immunity 
following daily inoculation with high dose of oocysts daily for 18 days (Augustin and Ridges, 
1963).  In the present study, around two weeks after the last inoculation dose, birds were 
challenged with a low dose of the parent strain.  Oocyst production was studied following the 
course of infection.  The birds inoculated with the parent strain and precocious line did not 
produce oocysts proving that the birds had developed a solid immunity.  Evaluation of 
pathogenicity of the precocious line was performed by analyzing body weight gain, feed 
consumption, feed conversion and dropping score.  A dose of 5 x 104 oocysts decreased body 
weight significantly compared to uninfected controls and such pathogenicity has been observed 
earlier (Clarkson, 1959; Hein, 1969; Long et al., 1977; Ruff et al., 1980).  The precocious line 
did not suppress body weight and the birds that received the line were comparable to uninfected 
controls. 
E. meleagrimitis is one of the most prevalent (Jeffers and Bentley, 1980; Edgar, 1986; 
Rathinam et al., unpublished observations) and pathogenic species of turkey Eimeria. Inclusion 
of a line that has been attenuated by selection for precocious development in live vaccines for 
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Table 1. Oocysts of Eimeria meleagrimitis recovered from turkey feces during selection for an 
attenuated strain based on precocious development  
Passage 
Oocysts/bird (x104) collected at time period indicated (hours after 
infection) 
100 104 108 112 116 120 124 128 144 
1 0 0 0 0 0 1.2 2.3 2.1 65.36 
2     0 1.7 4.6 7.5  
3     0.9 2.2 3.1 6.5  
4    0.4# 1.21 1.9 2.37 4.45  
5   0 0 1.41 2.73    
6    0.14 0.9 1.46 4.31   
7   0 0 0.75 3.25 2.90   
8    0.37 1.18 4.01 6.35   
9   0.15# 0.41 0.93 2.17 8.22   
10  0 0.19# 1.27 1.78 4.69    
11  0 0.63 2.45 9.98 4.23    
12  0 0.48 1.26 4.70 11.12    
13  0 0.23# 1.13 3.02 6.55    
14  0 0.55 1.29 1.31 6.19    
15  0 0.94 4.21 2.17 7.93    
16  0.06# 1.03 3.02 3.54 6.22    
17 0 0.23 1.09 4.45 7.21     
18 0 0.76 2.65 5.24 5.91     
19 0 1.37 3.01 6.08 9.63     
20 0 2.08 1.78 5.91 12.22     
 
* Values shown in bold were used for next passage 
# Infection with these oocysts did not produce oocysts in the subsequent passage 




Table 2. Body weight gain, feed consumption, feed conversion (Day 0-6) and fecal dropping 












     
Uninfected control 159±7a 257a 1.62b 0b 
Infected precocious 146±7a 210b 1.44b 0b 
Infected parent 65±4b 175c 2.73a 1.75a 
     
 
Values shown are mean± standard error of mean. Values along a column with different 





Table 3. Oocyst production of 4-week old turkeys immunized with either the precocious line or 
parent strain of Eimeria meleagrimitis following a challenge dose of 5x102 oocysts of the parent 
strain 
Immunization* Challenge Oocysts per bird (x106)** 
   
Non immunized control Yes 31.2 ± 7 
Precocious line Yes 0 ± 0 
Parent strain Yes 0 ± 0 
   
 
*Birds were immunized with 102, 103 and 104 oocysts of E. meleagrimitis parent strain or 
precocious line on Day 0, 7 and 14 respectively 







Fig. 1. Oocysts produced in feces per bird (mean±SEM) from 96 to 240 hours following an 




















Prolonged prophylactic usage of medication has resulted in Eimeria developing resistance to the 
anticoccidials drugs.  Vaccines currently available to control turkey coccidiosis contain virulent 
wild-type strains and pose a risk of clinical coccidiosis outbreak.  Hence, it would be beneficial 
to have vaccines with strains that are attenuated. 
The current study was aimed at identifying a drug-sensitive strain of a pathogenic species 
of Eimeria of turkey, E. meleagrimitis and attenuating it.  In the first part, Eimeria isolated from 
samples collected from turkey farms across the US were subjected to a drug sensitivity trial.  
They were tested for sensitivity to four commonly used anticoccidials drugs viz., amprolium, 
clopidol, monensin and diclazuril.  Most of the isolates were resistant to the drugs tested 
(Chapter 2).  In the next phase of the experiment (Chapter 3), identification of various species in 
samples collected from various farms was attempted using a polymerase chain reaction targeting 
the cytochrome c oxidase gene.  It was shown that E. meleagrimitis was the most prevalent 
species in all the isolates examined.  Following this, E. meleagrimitis was purified from a drug-
sensitive isolate (Minnesota strain) by isolating a single oocyst and propagated in live birds.  
Subsequently, the pathogenicity of the newly isolated strain was compared to a reference strain 
of E. meleagrimitis (Weybridge) and based on various performance parameters, was shown to be 
pathogenic (Chapter 4).  In the final chapter (Chapter 5), an attenuated line of E. meleagrimitis 
(Minnesota) was selected based on precocious development where the earliest oocysts produced 
following gametogony were collected, sporulated and propagated in a new batch of birds.  After 
20 such selections and propagations, the prepatent period had decreased from 120 hours to 104 




strain (designated the ‘parent’ strain) for pathogenicity, immunogenicity and fecundity.  It was 
shown that the attenuated line had significantly decreased pathogenicity and produced less 
number of oocysts and produced them earlier than the parent strain.  When birds were vaccinated 
with the attenuated line and challenged with the parent strain, no oocysts were produced 
indicating that the birds had developed protective immunity against E. meleagrimitis.   
In the present study, a drug-sensitive strain of E. meleagrimitis was identified and an 
attenuated line was developed from it and was shown that the new attenuated line was less 
pathogenic but maintained its immunogenicity.  Inclusion of a line that has been attenuated by 
selection for precocious development in live vaccines for turkeys will result in better control of 
coccidiosis. 
